Related Experiment Video
Updated: May 20, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen
Katherine L Cook1, Ayesha N Shajahan, Anni Wärri
1Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20057, USA.
Abstract:
While more than 70% of breast cancers express estrogen receptor-α (ER+), endocrine therapies targeting these receptors often fail. The molecular mechanisms that underlie treatment resistance remain unclear. We investigated the potential role of glucose-regulated protein 78 (GRP78) in mediating estrogen resistance. Human breast tumors showed increased GRP78 expression when compared with normal breast tissues. However, GRP78 expression was reduced in ER+ breast tumors compared with HER2-amplifed or triple-negative breast tumors. ER+ antiestrogen-resistant cells and ER+ tumors with an acquired resistant antiestrogen phenotype were both shown to overexpress GRP78, which was not observed in cases of de novo resistance. Knockdown of GRP78 restored antiestrogen sensitivity in resistant cells, and overexpression of GRP78 promoted resistance in sensitive cells. Mechanistically, GRP78 integrated multiple cellular signaling pathways to inhibit apoptosis and stimulate prosurvival autophagy, which was dependent on TSC2/AMPK-mediated mTOR inhibition but not on beclin-1. Inhibition of autophagy prevented GRP78-mediated endocrine resistance, whereas caspase inhibition abrogated the resensitization that resulted from GRP78 loss. Simultaneous knockdown of GRP78 and beclin-1 synergistically restored antiestrogen sensitivity in resistant cells. Together, our findings reveal a novel role for GRP78 in the integration of cellular signaling pathways including the unfolded protein response, apoptosis, and autophagy to determine cell fate in response to antiestrogen therapy.
Insights
Glucose-regulated protein 78 (GRP78) overexpression drives endocrine therapy resistance in estrogen receptor-positive (ER+) breast cancer by inhibiting apoptosis and promoting autophagy. Reducing GRP78 restores sensitivity to antiestrogen treatments.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Estrogen receptor-positive (ER+) breast cancer, comprising over 70% of cases, often develops resistance to endocrine therapies.
- The molecular mechanisms underlying this treatment resistance are not fully understood.
- Glucose-regulated protein 78 (GRP78) is investigated for its potential role in mediating this resistance.
Purpose of the Study:
- To investigate the role of glucose-regulated protein 78 (GRP78) in acquired antiestrogen resistance in ER+ breast cancer.
- To elucidate the molecular mechanisms by which GRP78 mediates endocrine resistance.
- To explore therapeutic strategies targeting GRP78 to overcome treatment resistance.
Main Methods:
- Analysis of GRP78 expression in human breast tumors and cell lines.
- Gene knockdown and overexpression experiments to assess GRP78's effect on antiestrogen sensitivity.
- Investigation of cellular signaling pathways, including apoptosis and autophagy, in response to GRP78 modulation.
- Pharmacological inhibition of autophagy and caspase pathways.
Main Results:
- GRP78 expression was increased in ER+ antiestrogen-resistant cells and tumors with acquired resistance, but not in de novo resistance.
- Knockdown of GRP78 restored antiestrogen sensitivity, while its overexpression induced resistance.
- GRP78 integrated signaling pathways to inhibit apoptosis and promote prosurvival autophagy via TSC2/AMPK-mediated mTOR inhibition.
- Inhibition of autophagy or combined knockdown of GRP78 and beclin-1 synergistically restored sensitivity.
Conclusions:
- GRP78 plays a critical role in mediating acquired endocrine resistance in ER+ breast cancer.
- GRP78 influences cell fate by integrating pathways like the unfolded protein response, apoptosis, and autophagy.
- Targeting GRP78 and/or autophagy presents a potential strategy to overcome antiestrogen resistance.
Related Concept Videos
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
